NCT06272500View on ClinicalTrials.gov

Safety and Efficacy Study of Betaine Hydrochloride in Treating Hypergastrinemia in Patients With Autoimmune Gastritis

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Autoimmune Gastritis
Interventions
OTHER

oral administration of receives only oral administration of placebo

receives oral administration of placebo, with two capsules before each meal.

DIETARY_SUPPLEMENT

oral administration of Betaine hydrochloride

receives oral administration of Betaine hydrochloride(BHCL), with two capsules before each meal.

Trial Locations (1)

436400

RECRUITING

First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
lead

Jianning Yao

OTHER